Missing dosages and neuroleptic usage may prolong length of stay in hospitalized Parkinson's disease patients

Parkinson's disease patients are more likely to be hospitalized, have higher rates of hospital complications, and have an increased risk of deterioration during hospitalization. Length of stay is an important underlying factor for these increased risks. We aimed to investigate potential medicat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2015-04, Vol.10 (4), p.e0124356-e0124356
Hauptverfasser: Martinez-Ramirez, Daniel, Giugni, Juan C, Little, Christopher S, Chapman, John P, Ahmed, Bilal, Monari, Erin, Wagle Shukla, Aparna, Hess, Christopher W, Okun, Michael S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e0124356
container_issue 4
container_start_page e0124356
container_title PloS one
container_volume 10
creator Martinez-Ramirez, Daniel
Giugni, Juan C
Little, Christopher S
Chapman, John P
Ahmed, Bilal
Monari, Erin
Wagle Shukla, Aparna
Hess, Christopher W
Okun, Michael S
description Parkinson's disease patients are more likely to be hospitalized, have higher rates of hospital complications, and have an increased risk of deterioration during hospitalization. Length of stay is an important underlying factor for these increased risks. We aimed to investigate potential medication errors that may occur during hospitalization and its impact on length of hospital stay. A cross-sectional chart review of 339 consecutive hospital encounters from 212 PD subjects was performed. Medication errors were defined as wrong timing or omission of administration for dopaminergic drugs and administration of contraindicated dopamine blockers. An analysis of covariance was applied to examine whether these medication errors were related to increased length of hospital stays. A significant effect for dopaminergic administration (p
doi_str_mv 10.1371/journal.pone.0124356
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1673954177</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A425368075</galeid><doaj_id>oai_doaj_org_article_56bef5d3bc2547acac44ef40003e462b</doaj_id><sourcerecordid>A425368075</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-b6a5b6cfa0fd26f62878d04cf581c2e6dba7b5a6987141959ec17534494db9703</originalsourceid><addsrcrecordid>eNqNk8tu1DAUhiMEomXgDRBYQuKymMH3JBukquIyUlERt63l2E7GxbFD7CDK0-PppNUM6gJ5Yev3d377HPsUxWMEV4iU6PVFmEYv3WoI3qwgwpQwfqc4RjXBS44hubu3PioexHgBISMV5_eLI8yqitKKHhf9Rxuj9R3QIcrORCC9Bt5MY3BmSFaBaSuDXl6CIWshk874Lm1AaEFMWbYebEIcbJLO_jEafJLjD-tj8C8i0DYaGQ0YZLLGp_iwuNdKF82jeV4U3969_Xr6YXl2_n59enK2VLzGadlwyRquWglbjXnLcVVWGlLVsgopbLhuZNkwyeuqRBTVrDYKlYxQWlPd1CUki-LpzndwIYq5UlEgXpKaUVSWmVjvCB3khRhG28vxUgRpxZUQxk7IMefvjGC8MS3TpFGY0VIqqSg1LYUQEkM5brLXm_m0qemNVjnTUboD08MdbzeiC78EpRDxqs4GL2eDMfycTEyit1EZ56Q3Ybq6N80cRlv02T_o7dnNVCdzAta3IZ-rtqbihGJGeAVzvRbF6hYqD216q_K3am3WDwJeHQRkJpnfqZNTjGL95fP_s-ffD9nne-zGSJc2Mbgp2eDjIUh3oBpDjKNpb4qMoNh2xXU1xLYrxNwVOezJ_gPdBF23AfkLvvMIyQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1673954177</pqid></control><display><type>article</type><title>Missing dosages and neuroleptic usage may prolong length of stay in hospitalized Parkinson's disease patients</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>Martinez-Ramirez, Daniel ; Giugni, Juan C ; Little, Christopher S ; Chapman, John P ; Ahmed, Bilal ; Monari, Erin ; Wagle Shukla, Aparna ; Hess, Christopher W ; Okun, Michael S</creator><creatorcontrib>Martinez-Ramirez, Daniel ; Giugni, Juan C ; Little, Christopher S ; Chapman, John P ; Ahmed, Bilal ; Monari, Erin ; Wagle Shukla, Aparna ; Hess, Christopher W ; Okun, Michael S</creatorcontrib><description>Parkinson's disease patients are more likely to be hospitalized, have higher rates of hospital complications, and have an increased risk of deterioration during hospitalization. Length of stay is an important underlying factor for these increased risks. We aimed to investigate potential medication errors that may occur during hospitalization and its impact on length of hospital stay. A cross-sectional chart review of 339 consecutive hospital encounters from 212 PD subjects was performed. Medication errors were defined as wrong timing or omission of administration for dopaminergic drugs and administration of contraindicated dopamine blockers. An analysis of covariance was applied to examine whether these medication errors were related to increased length of hospital stays. A significant effect for dopaminergic administration (p&lt;0.01) on length of hospital stay was observed. Subjects who had delayed administration or missed at least one dose stayed longer (M=8.2 days, SD=8.9 vs. M=3.6 days SD=3.4). Contraindicated dopamine blocking agents were administered in 23% (71/339) of cases, and this was also significantly related to an increased length of stay (M=8.2 days, SD=8.9 vs. M=3.6 days SD=3.4), p&lt;0.05. Participants who received a contraindicated dopamine blocker stayed in the hospital longer (M=7.5 days, SD=9.1) compared to those who did not (M=5.9 days, SD=6.8). Neurologists were consulted in 24.5% of encounters. Specialty consultation had no effect on the medication related errors. Missing dopaminergic dosages and administration of dopamine blockers occur frequently in hospitalized Parkinson's disease patients and this may impact length of stay. These potentially modifiable factors may reduce the risk of a longer stay related to hospitalization.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0124356</identifier><identifier>PMID: 25884484</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject><![CDATA[Accidental Falls - statistics & numerical data ; Aged ; Aged, 80 and over ; Analysis ; Antiparkinson Agents - administration & dosage ; Antipsychotic Agents - adverse effects ; Antipsychotic Agents - therapeutic use ; Comorbidity ; Complications ; Consultation ; Contraindications ; Covariance ; Cross-Sectional Studies ; Dementia ; Dopamine ; Dopamine Agents - administration & dosage ; Dopamine Antagonists - administration & dosage ; Dopamine Antagonists - adverse effects ; Dopamine receptors ; Drug administration ; Drug Administration Schedule ; Drugs ; Electronic Health Records ; Emergency medical care ; Family medical history ; Female ; Health care ; Health facilities ; Health maintenance organizations ; HMOs ; Hospitalization - statistics & numerical data ; Hospitals ; Humans ; Length of Stay - statistics & numerical data ; Male ; Martinez, Daniel ; Medical errors ; Medication Adherence ; Medication Errors ; Medicine ; Middle Aged ; Morbidity ; Mortality ; Movement disorders ; Neurodegenerative diseases ; Neurology ; Neurosurgery ; Older people ; Parkinson Disease - drug therapy ; Parkinson's disease ; Patients ; Population ; Ramirez, Michael ; Referral and Consultation - utilization ; Retrospective Studies ; Review boards ; Risk Factors ; Treatment Outcome]]></subject><ispartof>PloS one, 2015-04, Vol.10 (4), p.e0124356-e0124356</ispartof><rights>COPYRIGHT 2015 Public Library of Science</rights><rights>2015 Martinez-Ramirez et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2015 Martinez-Ramirez et al 2015 Martinez-Ramirez et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-b6a5b6cfa0fd26f62878d04cf581c2e6dba7b5a6987141959ec17534494db9703</citedby><cites>FETCH-LOGICAL-c692t-b6a5b6cfa0fd26f62878d04cf581c2e6dba7b5a6987141959ec17534494db9703</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401689/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401689/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79342,79343</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25884484$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Martinez-Ramirez, Daniel</creatorcontrib><creatorcontrib>Giugni, Juan C</creatorcontrib><creatorcontrib>Little, Christopher S</creatorcontrib><creatorcontrib>Chapman, John P</creatorcontrib><creatorcontrib>Ahmed, Bilal</creatorcontrib><creatorcontrib>Monari, Erin</creatorcontrib><creatorcontrib>Wagle Shukla, Aparna</creatorcontrib><creatorcontrib>Hess, Christopher W</creatorcontrib><creatorcontrib>Okun, Michael S</creatorcontrib><title>Missing dosages and neuroleptic usage may prolong length of stay in hospitalized Parkinson's disease patients</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Parkinson's disease patients are more likely to be hospitalized, have higher rates of hospital complications, and have an increased risk of deterioration during hospitalization. Length of stay is an important underlying factor for these increased risks. We aimed to investigate potential medication errors that may occur during hospitalization and its impact on length of hospital stay. A cross-sectional chart review of 339 consecutive hospital encounters from 212 PD subjects was performed. Medication errors were defined as wrong timing or omission of administration for dopaminergic drugs and administration of contraindicated dopamine blockers. An analysis of covariance was applied to examine whether these medication errors were related to increased length of hospital stays. A significant effect for dopaminergic administration (p&lt;0.01) on length of hospital stay was observed. Subjects who had delayed administration or missed at least one dose stayed longer (M=8.2 days, SD=8.9 vs. M=3.6 days SD=3.4). Contraindicated dopamine blocking agents were administered in 23% (71/339) of cases, and this was also significantly related to an increased length of stay (M=8.2 days, SD=8.9 vs. M=3.6 days SD=3.4), p&lt;0.05. Participants who received a contraindicated dopamine blocker stayed in the hospital longer (M=7.5 days, SD=9.1) compared to those who did not (M=5.9 days, SD=6.8). Neurologists were consulted in 24.5% of encounters. Specialty consultation had no effect on the medication related errors. Missing dopaminergic dosages and administration of dopamine blockers occur frequently in hospitalized Parkinson's disease patients and this may impact length of stay. These potentially modifiable factors may reduce the risk of a longer stay related to hospitalization.</description><subject>Accidental Falls - statistics &amp; numerical data</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Analysis</subject><subject>Antiparkinson Agents - administration &amp; dosage</subject><subject>Antipsychotic Agents - adverse effects</subject><subject>Antipsychotic Agents - therapeutic use</subject><subject>Comorbidity</subject><subject>Complications</subject><subject>Consultation</subject><subject>Contraindications</subject><subject>Covariance</subject><subject>Cross-Sectional Studies</subject><subject>Dementia</subject><subject>Dopamine</subject><subject>Dopamine Agents - administration &amp; dosage</subject><subject>Dopamine Antagonists - administration &amp; dosage</subject><subject>Dopamine Antagonists - adverse effects</subject><subject>Dopamine receptors</subject><subject>Drug administration</subject><subject>Drug Administration Schedule</subject><subject>Drugs</subject><subject>Electronic Health Records</subject><subject>Emergency medical care</subject><subject>Family medical history</subject><subject>Female</subject><subject>Health care</subject><subject>Health facilities</subject><subject>Health maintenance organizations</subject><subject>HMOs</subject><subject>Hospitalization - statistics &amp; numerical data</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Length of Stay - statistics &amp; numerical data</subject><subject>Male</subject><subject>Martinez, Daniel</subject><subject>Medical errors</subject><subject>Medication Adherence</subject><subject>Medication Errors</subject><subject>Medicine</subject><subject>Middle Aged</subject><subject>Morbidity</subject><subject>Mortality</subject><subject>Movement disorders</subject><subject>Neurodegenerative diseases</subject><subject>Neurology</subject><subject>Neurosurgery</subject><subject>Older people</subject><subject>Parkinson Disease - drug therapy</subject><subject>Parkinson's disease</subject><subject>Patients</subject><subject>Population</subject><subject>Ramirez, Michael</subject><subject>Referral and Consultation - utilization</subject><subject>Retrospective Studies</subject><subject>Review boards</subject><subject>Risk Factors</subject><subject>Treatment Outcome</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNk8tu1DAUhiMEomXgDRBYQuKymMH3JBukquIyUlERt63l2E7GxbFD7CDK0-PppNUM6gJ5Yev3d377HPsUxWMEV4iU6PVFmEYv3WoI3qwgwpQwfqc4RjXBS44hubu3PioexHgBISMV5_eLI8yqitKKHhf9Rxuj9R3QIcrORCC9Bt5MY3BmSFaBaSuDXl6CIWshk874Lm1AaEFMWbYebEIcbJLO_jEafJLjD-tj8C8i0DYaGQ0YZLLGp_iwuNdKF82jeV4U3969_Xr6YXl2_n59enK2VLzGadlwyRquWglbjXnLcVVWGlLVsgopbLhuZNkwyeuqRBTVrDYKlYxQWlPd1CUki-LpzndwIYq5UlEgXpKaUVSWmVjvCB3khRhG28vxUgRpxZUQxk7IMefvjGC8MS3TpFGY0VIqqSg1LYUQEkM5brLXm_m0qemNVjnTUboD08MdbzeiC78EpRDxqs4GL2eDMfycTEyit1EZ56Q3Ybq6N80cRlv02T_o7dnNVCdzAta3IZ-rtqbihGJGeAVzvRbF6hYqD216q_K3am3WDwJeHQRkJpnfqZNTjGL95fP_s-ffD9nne-zGSJc2Mbgp2eDjIUh3oBpDjKNpb4qMoNh2xXU1xLYrxNwVOezJ_gPdBF23AfkLvvMIyQ</recordid><startdate>20150417</startdate><enddate>20150417</enddate><creator>Martinez-Ramirez, Daniel</creator><creator>Giugni, Juan C</creator><creator>Little, Christopher S</creator><creator>Chapman, John P</creator><creator>Ahmed, Bilal</creator><creator>Monari, Erin</creator><creator>Wagle Shukla, Aparna</creator><creator>Hess, Christopher W</creator><creator>Okun, Michael S</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20150417</creationdate><title>Missing dosages and neuroleptic usage may prolong length of stay in hospitalized Parkinson's disease patients</title><author>Martinez-Ramirez, Daniel ; Giugni, Juan C ; Little, Christopher S ; Chapman, John P ; Ahmed, Bilal ; Monari, Erin ; Wagle Shukla, Aparna ; Hess, Christopher W ; Okun, Michael S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-b6a5b6cfa0fd26f62878d04cf581c2e6dba7b5a6987141959ec17534494db9703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Accidental Falls - statistics &amp; numerical data</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Analysis</topic><topic>Antiparkinson Agents - administration &amp; dosage</topic><topic>Antipsychotic Agents - adverse effects</topic><topic>Antipsychotic Agents - therapeutic use</topic><topic>Comorbidity</topic><topic>Complications</topic><topic>Consultation</topic><topic>Contraindications</topic><topic>Covariance</topic><topic>Cross-Sectional Studies</topic><topic>Dementia</topic><topic>Dopamine</topic><topic>Dopamine Agents - administration &amp; dosage</topic><topic>Dopamine Antagonists - administration &amp; dosage</topic><topic>Dopamine Antagonists - adverse effects</topic><topic>Dopamine receptors</topic><topic>Drug administration</topic><topic>Drug Administration Schedule</topic><topic>Drugs</topic><topic>Electronic Health Records</topic><topic>Emergency medical care</topic><topic>Family medical history</topic><topic>Female</topic><topic>Health care</topic><topic>Health facilities</topic><topic>Health maintenance organizations</topic><topic>HMOs</topic><topic>Hospitalization - statistics &amp; numerical data</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Length of Stay - statistics &amp; numerical data</topic><topic>Male</topic><topic>Martinez, Daniel</topic><topic>Medical errors</topic><topic>Medication Adherence</topic><topic>Medication Errors</topic><topic>Medicine</topic><topic>Middle Aged</topic><topic>Morbidity</topic><topic>Mortality</topic><topic>Movement disorders</topic><topic>Neurodegenerative diseases</topic><topic>Neurology</topic><topic>Neurosurgery</topic><topic>Older people</topic><topic>Parkinson Disease - drug therapy</topic><topic>Parkinson's disease</topic><topic>Patients</topic><topic>Population</topic><topic>Ramirez, Michael</topic><topic>Referral and Consultation - utilization</topic><topic>Retrospective Studies</topic><topic>Review boards</topic><topic>Risk Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Martinez-Ramirez, Daniel</creatorcontrib><creatorcontrib>Giugni, Juan C</creatorcontrib><creatorcontrib>Little, Christopher S</creatorcontrib><creatorcontrib>Chapman, John P</creatorcontrib><creatorcontrib>Ahmed, Bilal</creatorcontrib><creatorcontrib>Monari, Erin</creatorcontrib><creatorcontrib>Wagle Shukla, Aparna</creatorcontrib><creatorcontrib>Hess, Christopher W</creatorcontrib><creatorcontrib>Okun, Michael S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Martinez-Ramirez, Daniel</au><au>Giugni, Juan C</au><au>Little, Christopher S</au><au>Chapman, John P</au><au>Ahmed, Bilal</au><au>Monari, Erin</au><au>Wagle Shukla, Aparna</au><au>Hess, Christopher W</au><au>Okun, Michael S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Missing dosages and neuroleptic usage may prolong length of stay in hospitalized Parkinson's disease patients</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2015-04-17</date><risdate>2015</risdate><volume>10</volume><issue>4</issue><spage>e0124356</spage><epage>e0124356</epage><pages>e0124356-e0124356</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Parkinson's disease patients are more likely to be hospitalized, have higher rates of hospital complications, and have an increased risk of deterioration during hospitalization. Length of stay is an important underlying factor for these increased risks. We aimed to investigate potential medication errors that may occur during hospitalization and its impact on length of hospital stay. A cross-sectional chart review of 339 consecutive hospital encounters from 212 PD subjects was performed. Medication errors were defined as wrong timing or omission of administration for dopaminergic drugs and administration of contraindicated dopamine blockers. An analysis of covariance was applied to examine whether these medication errors were related to increased length of hospital stays. A significant effect for dopaminergic administration (p&lt;0.01) on length of hospital stay was observed. Subjects who had delayed administration or missed at least one dose stayed longer (M=8.2 days, SD=8.9 vs. M=3.6 days SD=3.4). Contraindicated dopamine blocking agents were administered in 23% (71/339) of cases, and this was also significantly related to an increased length of stay (M=8.2 days, SD=8.9 vs. M=3.6 days SD=3.4), p&lt;0.05. Participants who received a contraindicated dopamine blocker stayed in the hospital longer (M=7.5 days, SD=9.1) compared to those who did not (M=5.9 days, SD=6.8). Neurologists were consulted in 24.5% of encounters. Specialty consultation had no effect on the medication related errors. Missing dopaminergic dosages and administration of dopamine blockers occur frequently in hospitalized Parkinson's disease patients and this may impact length of stay. These potentially modifiable factors may reduce the risk of a longer stay related to hospitalization.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>25884484</pmid><doi>10.1371/journal.pone.0124356</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2015-04, Vol.10 (4), p.e0124356-e0124356
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1673954177
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS)
subjects Accidental Falls - statistics & numerical data
Aged
Aged, 80 and over
Analysis
Antiparkinson Agents - administration & dosage
Antipsychotic Agents - adverse effects
Antipsychotic Agents - therapeutic use
Comorbidity
Complications
Consultation
Contraindications
Covariance
Cross-Sectional Studies
Dementia
Dopamine
Dopamine Agents - administration & dosage
Dopamine Antagonists - administration & dosage
Dopamine Antagonists - adverse effects
Dopamine receptors
Drug administration
Drug Administration Schedule
Drugs
Electronic Health Records
Emergency medical care
Family medical history
Female
Health care
Health facilities
Health maintenance organizations
HMOs
Hospitalization - statistics & numerical data
Hospitals
Humans
Length of Stay - statistics & numerical data
Male
Martinez, Daniel
Medical errors
Medication Adherence
Medication Errors
Medicine
Middle Aged
Morbidity
Mortality
Movement disorders
Neurodegenerative diseases
Neurology
Neurosurgery
Older people
Parkinson Disease - drug therapy
Parkinson's disease
Patients
Population
Ramirez, Michael
Referral and Consultation - utilization
Retrospective Studies
Review boards
Risk Factors
Treatment Outcome
title Missing dosages and neuroleptic usage may prolong length of stay in hospitalized Parkinson's disease patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T16%3A55%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Missing%20dosages%20and%20neuroleptic%20usage%20may%20prolong%20length%20of%20stay%20in%20hospitalized%20Parkinson's%20disease%20patients&rft.jtitle=PloS%20one&rft.au=Martinez-Ramirez,%20Daniel&rft.date=2015-04-17&rft.volume=10&rft.issue=4&rft.spage=e0124356&rft.epage=e0124356&rft.pages=e0124356-e0124356&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0124356&rft_dat=%3Cgale_plos_%3EA425368075%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1673954177&rft_id=info:pmid/25884484&rft_galeid=A425368075&rft_doaj_id=oai_doaj_org_article_56bef5d3bc2547acac44ef40003e462b&rfr_iscdi=true